Approved targeted drugs for HER2 -mutant NSCLC include trastuzumab deruxtecan (T-DXd, Enhertu) -- which is highly effective ...

Stage 0 cancer, known as carcinoma in situ, marks the earliest stage of cancer development. Abnormal cells are present but ...

An agency within the Department of Health and Human Services has awarded Carnegie Mellon University researchers $26.7 million to develop a single at-home cancer screening system using synthetic ...

FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma ...

Stage 0 cancer, or carcinoma in situ, represents the earliest detectable phase where abnormal cells are confined to their ...

Ovarian cancer has been described as a “silent killer” because it often goes unnoticed until it reaches an advanced stage, according to Obstetrician-Gynecologist, Professor Samuel Antwi Oppong.

A healthy mouth is a window to a healthy body. Oral hygiene is not merely about having a bright smile — it is deeply linked ...

Read the daily horoscope for October 26, 2025, to gain insights into your health, relationships, career, and emotions. Plan ...

A test in the Triad that can tell if you have an increased chance of breast cancer, ovarian cancer, colon cancer and heart ...

To help a loved one with cancer, think about what you're good at — and what they need. Are you organized? Plan their meals.

Get our top stories delivered straight to your inbox.

FX-909, the first small molecule targeting PPARG to be tested in humans, showed monotherapy activity in advanced urothelial ...